Home » Topics » Disease categories and therapies » Infection

Infection
RSS

FDA approves Gensia's injectable acyclovir

Aug. 29, 1997

Faulding's generic acyclovir receives FDA approval

Aug. 29, 1997

Marketing agreement reached for Abelcet in France and Italy

Aug. 28, 1997

BMS reports new cephalosporins active against MRSA

Aug. 28, 1997

Data sheet for Lariam updated

Aug. 27, 1997

RespiGam approved for marketing in Canada

Aug. 25, 1997

Supplemental NDA approved for Cipro

Aug. 22, 1997

Chlorhexidine solution prevents perinatal infections

Aug. 22, 1997

GT35 described in patent literature by Kyowa Hakko

Aug. 20, 1997

Positive phase III results for Lidakol in oral herpes

Aug. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...